Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

AZD1222 Clinical Trials Resume in the UK

September 13, 2020

Clinical trials for AZD1222 coronavirus vaccine resume in the UK as per guidance by MHRA.

AstraZeneca Pauses Clinical Trial on COVID-19 Vaccine for Safety Review

September 08, 2020

The clinical trials of the AstraZeneca Oxford COVID-19 vaccine, AZD1222, have been paused for a safety review as a result of an incident of an unexplained illness in a UK trial patient.

Vaccine Developers Pledge to Stand with Science

September 08, 2020

As public confidence in the drug development process waivers, leading vaccine developers promise to adhere to scientific and regulatory principles.

Preparing Pandemic Vaccine Capacity

September 03, 2020

Rapid scale-up to billions of doses requires collaborative, all-out efforts by innovators, their manufacturing partners, and the entire supply chain.

Capsule Innovations: Speeding Up Drug Development

September 03, 2020

Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations.

Manufacturing Drug–Device Combination Products

September 03, 2020

A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing.

Making the Ideal Dosage Form

September 02, 2020

End-user considerations are becoming increasingly important as they can provide a lot of value and help to ensure commercial success of a drug.

Solid-Dose Continuous Manufacturing Presses On

September 02, 2020

Early adopters and equipment manufacturers refine their equipment and processes, paving the way for broader use.

Catalent to Manufacture Drug Substance for AstraZeneca’s COVID-19 Vaccine Candidate

August 24, 2020

Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.

EC Reaches Agreement with AstraZeneca on Purchase of COVID-19 Vaccine

August 20, 2020

EC finalizes agreement to purchase millions of doses of AstraZeneca's COVID-19 vaccine.